Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening
- PMID: 20714305
- PMCID: PMC6257681
- DOI: 10.3390/molecules15085408
Using topological indices to predict anti-Alzheimer and anti-parasitic GSK-3 inhibitors by multi-target QSAR in silico screening
Abstract
Plasmodium falciparum, Leishmania, Trypanosomes, are the causers of diseases such as malaria, leishmaniasis and African trypanosomiasis that nowadays are the most serious parasitic health problems worldwide. The great number of deaths and the few drugs available against these parasites, make necessary the search for new drugs. Some of these antiparasitic drugs also are GSK-3 inhibitors. GSKI-3 are candidates to develop drugs for the treatment of Alzheimer's disease. In this work topological descriptors for a large series of 3,370 active/non-active compounds were initially calculated with the ModesLab software. Linear Discriminant Analysis was used to fit the classification function and it predicts heterogeneous series of compounds like paullones, indirubins, meridians, etc. This study thus provided a general evaluation of these types of molecules.
Figures
Similar articles
-
First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.Mol Divers. 2011 May;15(2):561-7. doi: 10.1007/s11030-010-9280-3. Epub 2010 Oct 8. Mol Divers. 2011. PMID: 20931280
-
QSAR, docking, and CoMFA studies of GSK3 inhibitors.Curr Pharm Des. 2010;16(24):2666-75. doi: 10.2174/138161210792389225. Curr Pharm Des. 2010. PMID: 20642432 Review.
-
Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases.Parasitology. 2011 May;138(6):725-35. doi: 10.1017/S0031182011000151. Epub 2011 Feb 24. Parasitology. 2011. PMID: 21349219
-
Theoretical study of GSK-3α: neural networks QSAR studies for the design of new inhibitors using 2D descriptors.Mol Divers. 2011 Nov;15(4):947-55. doi: 10.1007/s11030-011-9325-2. Epub 2011 Jul 7. Mol Divers. 2011. PMID: 21735119
-
Predicting drugs and proteins in parasite infections with topological indices of complex networks: theoretical backgrounds, applications, and legal issues.Curr Pharm Des. 2010;16(24):2737-64. doi: 10.2174/138161210792389234. Curr Pharm Des. 2010. PMID: 20642428 Review.
Cited by
-
On Molecular Descriptors of Carbon Nanocones.Biomolecules. 2018 Sep 7;8(3):92. doi: 10.3390/biom8030092. Biomolecules. 2018. PMID: 30205520 Free PMC article.
-
In Silico Drug Repurposing for Anti-Inflammatory Therapy: Virtual Search for Dual Inhibitors of Caspase-1 and TNF-Alpha.Biomolecules. 2021 Dec 4;11(12):1832. doi: 10.3390/biom11121832. Biomolecules. 2021. PMID: 34944476 Free PMC article.
-
Glycogen Synthase Kinase-3 (GSK-3)-Targeted Therapy and Imaging.Theranostics. 2016 Feb 17;6(4):571-93. doi: 10.7150/thno.14334. eCollection 2016. Theranostics. 2016. PMID: 26941849 Free PMC article. Review.
-
Alzheimer: A Decade of Drug Design. Why Molecular Topology can be an Extra Edge?Curr Neuropharmacol. 2018;16(6):849-864. doi: 10.2174/1570159X15666171129102042. Curr Neuropharmacol. 2018. PMID: 29189164 Free PMC article. Review.
-
Combined structure-based pharmacophore and 3D-QSAR studies on phenylalanine series compounds as TPH1 inhibitors.Int J Mol Sci. 2012;13(5):5348-5363. doi: 10.3390/ijms13055348. Epub 2012 May 2. Int J Mol Sci. 2012. PMID: 22754301 Free PMC article.
References
-
- Olson R.E. Secretase inhibitors as therapeutics for Alzheimer’s disease. Annu. Rep. Med. Chem. 2000;35:31–40. doi: 10.1016/S0065-7743(00)35005-9. - DOI
-
- Brion J.P., Anderton B.H., Authelet M., Dayanandan R., Leroy K., Lovestone S., Ocatve J.N., Pradier L., Touchet N., Tremp G. Neurofibrillary Tangles and Tau Phosphorilation. Biochem. Soc. Symp. 2001;67:81–88. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical